Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Cardiawave logo — Cardiawave is developing an innovative and non-invasive ultr...

Cardiawave

Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis.

Founded 2014 France France 33 employees Grant Total: $13.31M Health Care, Medical Devices

General Information

Company Name Cardiawave
Founded Year 2014
Location France France
Employees 33
Industries Health Care, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Cardiawave. To contact Cardiawave, visit cardiawave.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Cardiawave compare?

A PDF of Cardiawave and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Cardiawave soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Cardiawave

Cardiawave is a clinical-stage company founded in 2014 and based in France, aiming to combat aortic valve stenosis, a life-threatening condition affecting approximately 10 million people in Western countries. The company has attracted attention by winning multiple innovation prizes and is backed by a significant €3.56MGrant investment from EASME - EU Executive Agency for SMEs as of 01 January 2019. Cardiawave has partnered with esteemed institutions such as the Langevin Institute \/ Physics for Medicine Paris and the Georges Pompidou European Hospital (HEGP) to develop a groundbreaking non-invasive image-guided medical device (MD) that employs focused ultrasound therapy to soften aortic valve leaflets and improve valve opening. This innovative approach holds tremendous promise in addressing a condition that poses a major public health concern. With its strong strategic alliances and pioneering technology, Cardiawave positions itself as a key player in revolutionizing treatment methodologies within the Health Care industry.

Business keywords: medical device, non-invasive treatment, aortic valve stenosis, ultrasound therapy, clinical-stage startup, innovative technology, image-guided therapy, Langevin Institute, Georges Pompidou European Hospital, cardiovascular health, award-winning, partnership, biomedical engineering

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €3.56M 1
EASME - EU Executive Agency for SMEs
01 Jan 2019
Venture Round $8.20M 6
Angels Santé Sofimac Innovation BADGE Business Angels des Grandes Ecoles
Angels Santé, Sofimac Innovation +4
27 Sep 2018
Venture Round €1.40M 5
Angels Santé BADGE Business Angels des Grandes Ecoles Angels’ Bay Invest
Angels Santé, BADGE Business Angels des Grandes Ecoles +3
02 Mar 2017
Seed Round Undisclosed 1
Le Studio VC
Le Studio VC
01 Dec 2015
Pre Seed Round €150.00K 1
WILCO
WILCO
21 May 2015
Seed Round Undisclosed 1
AGORANOV
AGORANOV
01 May 2015

Latest News

View All
EIC Scaling Club'a katılan 72 teknoloji şirketi — Webrazzi
EIC Scaling Club'a katılan 72 teknoloji şirketi
Webrazzi Oct 21, 2024

Cardiawave Alternatives & Competitors

View All Alternatives
Cardiawave vs
Pi-Cardia
Pi-Cardia Israel

Leading the way for leaflet modification

Debt Financing
59 employees
Health Care, Medical Devices
Compare Cardiawave vs Pi-Cardia
Cardiawave vs
JenaValve Technology, Inc.
JenaValve Technology, Inc. United States

Aortic regurgitation is different. So is our valve.

Series C
149 employees
Health Care, Manufacturing
Compare Cardiawave vs JenaValve Technology, Inc.
Cardiawave vs
Novostia
Novostia Switzerland

Heart valves for life, for patients of any age, including children

15 employees
Health Care, Medical Devices
View all alternatives

FAQ About Cardiawave

Cardiawave is developing an innovative and non-invasive ultrasound treatment of aortic stenosis.
Cardiawave was founded in 2014.
Cardiawave is headquartered in France.
Cardiawave operates in Health Care and Medical Devices. Its work centres on medical device, non-invasive treatment, aortic valve stenosis and ultrasound therapy.
Cardiawave has approximately 33 employees.
Cardiawave has completed 6 funding rounds, raising a total of $13.31M. The latest funding stage is Grant.
Top alternatives and competitors to Cardiawave include Pi-Cardia, JenaValve Technology, Inc., Novostia, Carthera, Taurus Vascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Cardiawave and Pi-Cardia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Cardiawave, https://bouncewatch.com/company/cardiawave, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout